Drug Delivery Report

Welcome to the Opportunities database, one of the most visited pages of the entire website. If you are looking to initiate deals then make sure your opportunity is listed here.

Clinical Electroporation System for Delivery of DNA Drugs
Administration route Intratumoural, Intramuscular
Indication DNA plasmid drug delivery
Licence code LO-0608-06

7 Day Discreet Transdermal Pain Patch
Administration route Transdermal
Indication Moderate-to-severe chronic pain
Licence code LO-0805-05

Mannan-Linked DNA/RNA Delivery
Administration route Undisclosed
Indication Infectious diseases, cancer, gene therapy
Licence code LO-0606-07

Sustained-Release Lipid Inhaled Targeting Drug Delivery Technology
Administration route Inhalation
Indication Respiratory Diseases
Licence code LO-0606-01

Compositions and Methods for Targetting Peptides to the CNS
Administration route Undisclosed
Indication Alzheimer's disease, Parkinson's disease, prion diseases
Licence code LO-0406-42

Targeted Microparticles and Nanoparticles
Administration route Undisclosed
Indication Lipidated glycosaminoglycan microparticles or nanoparticles, which can encapsulate DNA, proteins and small molecules with high efficiency
Licence code LO-0406-19

Novel Biomedical Polymer Technology
Administration route Ophthalmic, Transdermal, Subcutaneous, Topical
Indication Improve the acceptance of implants and medical devices; particularly designed for optical lenses and drug delivery
Licence code LO-0106-03

Improved Vaccine Delivery: Virus-Like Particles
Administration route Undisclosed
Indication HIV, hepatitis B, hepatitis C, allergies, cancer
Licence code LO-1105-16

Product to Prevent Restenosis
Administration route Drug eluting stent
Indication Restenosis
Licence code LO-1105-08

Acetylcholinesterase Inhibitor and Long-Acting Neuroprotectant
Administration route Oral
Indication Alzheimer's disease
Licence code LO-0905-07

Sustained-Release Prostate Cancer Treatment
Administration route Intravenous
Indication Prostate cancer
Licence code LO-1105-02

Transdermal Administration of Pain Relief Agent
Administration route Transdermal, topical
Indication Pain management
Licence code LO-0805-06

Liposomal Topotecan
Administration route Intravenous
Indication Cancer
Licence code LO-1005-04

Bioavailable Oral Drug Formulations
Administration route Oral
Indication Enhancement of the bioavailability of oral drug formulations
Licence code LO-1005-10

Fast-Acting Oral NSAIDS
Administration route Sublingual, oral
Indication Mild-to-moderate pain relief
Licence code LO-1005-03

Huntington's Disease Treatment
Administration route Intracerebral, injection
Indication Huntington's disease
Licence code LO-1005-07

Liposomal Vincristine
Administration route Intravenous
Indication Cancer, including non-Hodgkin's lymphoma and acute lymphoblastic
Licence code LO-1005-05

Treatment of Rheumatoid Arthritis and Inflammatory Joint Diseases
Administration route Injection
Indication Inflammatory joint diseases
Licence code LO-1005-06

Drug Delivery Technologies
Administration route Oral
Indication Drug delivery technologies
Licence code LO-1005-08